Trading Tech Providers Itiviti and Ullink Announce Merger

Itiviti and Ullink are merging their operations and offerings, with managed solutions a key driver for the deal.

stockholm
Stockholm-based Itiviti will quadruple its client base across the sell and buy sides through its acquisition of Ullink.

Itiviti, which is backed by Nordic Capital Fund VII, is to merge with Ullink and integrate its suite of buy-side-focused products. Itiviti’s portfolio of sell-side trading solutions, which includes Catalys, a front- and middle-office fixed-income infrastructure platform, and Tbricks, a modular platform for algorithmic, basket, hedge and spread trading, will be merged with that of Ullink, most notably, the FIX order routing network, Nyfix, and the firm’s equities and derivatives platforms.

Torbe

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Banks seemingly build more than buy, but why?

Waters Wrap: A new report states that banks are increasingly enticed by the idea of building systems in-house, versus being locked into a long-term vendor contract. Anthony explores the reason for this shift.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here